Microemulsions: Pharmaceutical Applications

Microemulsions: Background, New Concepts, Applications, Perspectives

Volumn , Issue , 2009, Pages 259-301

  Patravale, Vandana B ^a   Date, Abhijit A ^b  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

Active pharmaceutical ingredient (API); Aqueous phase; Co surfactants; Formulation of microemulsions; Microemulsion characterisation and evaluation; Microemulsions and pharmaceutical applications; Ocular drug delivery applications; Pharmaceutical microemulsions; Potential mechanisms for improved dermal transdermal transport

Indexed keywords

EID: 84890711648     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444305524.ch9     Document Type: Chapter

References (163)

1. Lipinski, C. (2002) Poor aqueous solubility -an industry wide problem in drug discovery. Am. Pharm. Rev., 5, 82-85.
2. Amidon, G.L., Lennernas, H., Shah, V.P. and Crison, J. (1995) A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitrodrug product dissolution and in vivobioavailability. Pharm. Res., 12, 413-420.
3. Waterbeemd, H. (1998) The fundamental variables of the biopharmaceutics classification system (BCS): A commentary. Eur. J. Pharm. Sci., 7, 1-3.
4. Lawrence M. J. and Rees, G.D. (2000) Microemulsion-based media as novel drug delivery Systems. Adv. Drug Deliv. Rev., 45, 89-121.
5. Lv, F.F., Li, N. Zheng, L.Q. and Tung, C.H. (2006) Studies on the stability of the chloramphenicol in the microemulsion free of alcohols. Eur. J. Pharm. Biopharm., 62, 288-294.
6. Gallarate, M., Carlotti, M.E., Trotta, M., Grande, A.E. and Talarico, C. (2004) Photostability of naturally occurring whitening agents in cosmetic microemulsions. J. Cosmet. Sci., 55, 139-148.
7. Sarciaux, J.M., Acar, L. and Sado, P.A. (1995) Using microemulsion formulations for oral drug delivery of therapeutic peptides. Int. J. Pharm., 120, 127-136.
8. Kang, B.K., Lee, J.S., Chon S.K., Jeong, S.Y., Yuk, S.H., Khang, G., Lee, H.B. and Cho, S.H. (2004) Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int. J. Pharm., 274, 65-73.
9. Wei, L., Sun, P., Nie, S. and Pan, W. (2005) Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev. Ind. Pharm., 31, 785-794.
10. Kreilgaard, M. (2002) Influence of microemulsions on cutaneous drug delivery. Adv. Drug. Deliv. Rev., 54(Suppl. 1), S77-S98.
11. Müller, R.H., Mäder, K. and Gohla, S. (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery -a review of the state of the art. Eur. J. Pharm. Biopharm., 50, 161-178.
12. Patravale, V.B., Date, A.A. and Kulkarni, R. (2004) Nanosuspensions: A promising drug delivery strategy. J. Pharm. Pharmacol., 56, 827-840.
13. Malcolmson, C., Satra, C., Kantaria, S., Sidhu, A. and Lawrence, M.J. (1998) Effect of the nature of oil on the incorporation of testosterone propionate into non-ionic oil-in-water microemulsions. J. Pharm. Sci., 87, 109-116.
14. Warisnoicharoen, W., Lansley, A.B. and Lawrence, M.J. (2000) Non-ionic oil-in-water mi-croemulsions: The effect of oil type on phase behavior. Int. J. Pharm., 198, 7-27.
15. Vandamme, T.F. (2002) Microemulsions as ocular drug delivery systems: Recent developments and future challenges. Prog. Ret. Eye Res., 21, 15-34.
16. Gursoy, N. and Benita, S. (2004) Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother., 58, 173-182.
17. Lundin, P., Bojrup, M., Ljusberg-Wahren, H., Westrom, B.R. and Lundin, S. (1997) Enhancing effects of monohexanoin and two other medium-chain glyceride vehicles on intestinal absorption of desmopressin (Ddavp). J. Pharm. Exp. Ther., 282, 585-590.
18. Akers, M.J. (2002) Excipient-drug interactions in parenteral formulations. J. Pharm. Sci., 91, 2283-2300.
19. Strickley, R.G. (2004) Solubilizing excipients in oral and injectable formulations. Pharm. Res., 21, 201-230.
20. Tije, A.J., Verweij, J., Loos, W.J. and Spareboom, A. (2003) Pharmacological effects of formulation vehicles implications for cancer chemotherapy. Clin. Pharmacokinet., 42, 665-685.
21. Stilbs, P., Lindman, B. and Rapacki, K. (1983) Effect of alcohol cosurfactant length on microemulsion structure. J. Colloid Interface Sci., 95, 583-585.
22. Yaghmur, A., Aserin, A. and Garti, N. (2002) Phase behaviour of microemulsions based on food-grade non-ionic surfactants: Effect of polyols and short-chain alcohols. Colloid Surf. A, 209, 71-81.
23. Tenjarla, S. (1999) Microemulsions: An overview and pharmaceutical applications. Crit. Rev. Ther. Drug Carrier Syst., 16, 461-521.
24. Alany, R.G., Rades, T., Agatonovic-Kustrin, S., Davies, N.M. and Tucker, I.G. (2000) Effects of alcohols and diols on the phase behaviour of quaternary systems. Int. J. Pharm., 196, 141-145.
25. Flanagan, J. and Singh, H. (2006) Microemulsions: A potential delivery system for bioactives in food. Crit. Rev. Food Sci. Nutr., 46, 221-237.
26. Attwood, D. (1994) Microemulsions. In J. Kreuter (ed), Colloidal Drug Delivery Systems.Marcel Dekker, New York, pp. 31-71.
27. Eccleston, J. (1994) Microemulsions. In J. Swarbick and J.C. Boylan (eds), Encyclopedia of Pharmaceuticaltechnology.Marcel Dekker, New York, pp. 375-421.
28. Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K., Nishihara, Y. and Masuda, K. (2002) Microemulsion formulation for enhanced absorption of poorly soluble drugs I. Prescription design. J. Control. Release, 81, 65-74.
29. Zhang, X., Dong, J., Zhang, G., Hong, X. and Li, X. (2005) The effects of additives on the water solubilization capacity and conductivity in n-pentanol microemulsions. J. Colloid Interface Sci., 285, 336-341.
30. Roy, B.K. and Moulik, S.P. (2002) Functions of hydrotropes (sodium salicylate, proline, pyro-gallol, resorcinol and urea) in solution with special reference to amphiphile behaviors. Colloid Surf. A, 203, 155-166.
31. Gasco, M.R. (1997) Solid lipid nanospheres form warm microemulsions. Pharm. Technol. Eur., 9, 32-42.
32. Djordjevic, L., Primorac, M., Stupar, M. and Krajisnik, D. (2004) Characterization of capry-locaproyl macrogolglycerides based microemulsion drug delivery vehicles for an Amphiphilic drug. Int. J. Pharm., 271, 11-19.
33. Joubran, R.F., Cornell, D.G. and Parris, N. (1993) Microemulsions of triglyceride and non-ionic surfactant-effect of temperature and aqueous phase composition. Colloid Surf. A, 80, 153-157.
34. Flanagan, J., Kortegaard, K., Neil-Pinder, D., Rades, T. and Singh, H. (2006) Solubilisation of soybean oil in microemulsions using various surfactants. Food Hydrocolloids, 20, 253-260.
35. Pes, M.A., Aramaki, K., Nakamura, N. and Kunieda, H. (1996) Temperature-insensitive mi-croemulsions in a sucrose monoalkanoate system. J. Colloid Interface Sci., 178, 666-672.
36. Bagwe, R.P., Kanicky, J.R., Palla, B.J., Patanjali, P.K. and Shah, D.O. (2001) Improved drug delivery using microemulsions: Rationale, recent progress, and new horizons. Crit. Rev. Ther. Drug Carrier Syst., 18, 77-140.
37. Foldvarim, M. (2000) Non-invasive administration of drugs through the skin: Challenges in delivery system design. Pharm. Sci. Tech. Today, 3, 417-425.
38. Benson, H.A.E. (2005) Transdermal drug delivery: Penetration enhancement techniques. Curr. Drug Deliv., 2, 23-33.
39. Brown, M.B., Martin, G.P., Jones, S.A. and Akomeah, F.K. (2006) Dermal and transdermal drug delivery systems: Current and future prospects. Drug Deliv., 13, 175-187.
40. Ting, W., Vest, C. and Sontheimer, R. (2004) Review of traditional and novel modalities that enhance the permeability of local therapeutics across the stratum corneum. Int. J. Dermatol., 43, 538-547.
41. Stott, P.W., Williams, A.C. and Barry, B.W. (2001) Mechanistic study into the enhanced trans-dermal permeation of a model R-blocker, propranolol, by fatty acids: A melting point depression effect. Int. J. Pharm., 219, 161-176.
42. Kogan, A. and Garti, N. (2006) Microemulsions as transdermal drug delivery vehicles. Adv. Colloid Interface Sci., 123-126, 369-385.
43. Gloor, M., Haus, G. and Keipert, S. (2003) Keratolytic activity of microemulsions. Skin Pharmacol. Physiol., 16, 151-155.
44. Changez M., Varshney, M., Chander, J. and Dinda, A.K. (2006) Effect of the composition of lecithin/n-propanol/isopropyl myristate/water microemulsions on barrier properties of mice skin for transdermal permeation of tetracaine hydrochloride: In vitro. Colloid Surf. B, 50, 18-25.
45. Kemken, J., Ziegler, A. and Mueller, B.W. (1992) Influence of supersaturation on the pharma-codynamic effect of bupranolol after dermal administration using microemulsions as vehicle. Pharm. Res., 9, 554-558.
46. Peltola, S., Saarinen-Savolainen, P., Kiesvaara, J., Suhonen, T.M. and Urtti, A. (2003) Microemulsions for topical delivery of estradiol. Int. J. Pharm., 254, 99-107.
47. Biju, S.S., Ahuja, A. and Khar, R.K. (2005) Tea tree oil concentration in follicular casts after topical delivery: Determination by high-performance thin layer chromatography using a perfused bovine udder model. J. Pharm. Sci., 94, 240-245.
48. Escribano, E., Obach, M., Arévalo, M.I., Calpena, A.C., Domenech, J. and Queralt, J. (2005) Rapid human skin permeation and topical anaesthetic activity of a new amethocaine mi-croemulsion. Skin Pharmacol. Physiol., 18, 294-300.
49. Shukla, A., Krause, A. and Neubert, R.H.H. (2003) Microemulsions as colloidal vehicle systems for dermal drug delivery. Part IV: Investigation of microemulsion systems based on a eutectic mixture of lidocaine and prilocaine as the colloidal phase by dynamic light scattering. J. Pharm. Pharmacol., 55, 741-748.
50. Kreilgaard, M., Pedersen, E.J. and Jaroszewski, J.W. (2000) NMR characterisation and trans-dermal drug delivery potential of microemulsion systems. J. Control. Release, 69, 421-433.
51. Sintov, A.C. and Shapiro, L. (2004) New microemulsion vehicle facilitates percutaneous pene-tration in vitro and cutaneous drug bioavailability in vivo. J. Control. Release, 95, 73-183.
52. Lee, P.J., Langer, R. and Shastri, V.P. (2003) Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs. Pharm. Res., 20, 264-269.
53. Wang, D.K., Shi, Z.H., Liu, L., Wang, X.Y., Zhang, C.X. and Zhao, P. (2006) Development of selfmicroemulsifying drug delivery systems for oral bioavailability enhancement of alpha-asarone in beagle dogs. PDA J. Pharm. Sci. Technol., 60, 343-349.
54. Kreilgaard, M. (2001) Dermal pharmacokinetics of microemulsion formulations determined by in vivo microdialysis. Pharm. Res., 18, 367-373.
55. Kreilgaard, M., Kemme, M.J.B., Burggraaf, J., Schoemaker, R.C. and Cohen, A.F. (2001) In-fluence of a microemulsion vehicle on cutaneous bioequivalence of a lipophilic model drug assessed by microdialysis and pharmacodynamics. Pharm. Res., 18, 593-599.
56. Changez, M. and Varshney, M. (2000) Aerosol-OT microemulsions as transdermal carriers of tetracaine hydrochloride. Drug Dev. Ind. Pharm., 26, 507-512.
57. Changez, M., Chander, J. and Dinda, A.K. (2006) Transdermal permeation of tetracaine hy-drochloride by lecithin microemulsion: In vivo. Colloid Surf. B, 48, 58-66.
58. Kriwet, K. and Muller-Goymann, C.C. (1995) Diclofenac release from phospholipid drug systems and permeation through excised human stratum corneum. Int. J. Pharm., 125, 231-242.
59. Kweon, J.H., Chi, S.C. and Park, E.S. (2004) Transdermal delivery of diclofenac using mi-croemulsions. Arch. Pharm. Res., 27, 351-356.
60. Sintov, A.C. and Botner, S. (2006) Transdermal drug delivery using microemulsion and aqueous systems: Influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems. Int. J. Pharm., 311, 55-62.
61. Park, E.S, Cui, Y., Yun, B.J., Ko, I.J. and Chi, S.C. (2005) Transdermal delivery of piroxicam using microemulsions. Arch. Pharm. Res., 28, 243-248.
62. Yuan, Y., Li, S., Mo, F.K. and Zhong, D.F. (2006) Investigation of microemulsion system for transdermal delivery of meloxicam. Int. J. Pharm., 321, 117-123.
63. Chen H., Chang, X., Du, D., Li, J., Xu, H. and Yang, X. (2006) Microemulsion-based hydrogel formulation of ibuprofen for topical delivery. Int. J. Pharm., 315, 52-58.
64. Subramanian, N., Ghosal, S.K. and Moulik, S.P. (2005) Enhanced in vitro percutaneous absorption and in vivo anti-inflammatory effect of a selective cyclooxygenase inhibitor using microemulsion. Drug Dev. Ind. Pharm., 31, 405-416.
65. Desai, K.G.H. (2004) Enhanced skin permeation of rofecoxib using topical microemulsion gel. Drug Dev. Res., 63, 33-40.
66. Bolzinger, M.A., Carduner, T.C. and Poelman, M.C. (1998) Bicontinuous sucrose ester mi-croemulsion: A new vehicle for topical delivery of niflumic acid. Int. J. Pharm., 176, 39-45.
67. Dalmora, M.E., Dalmora, S.L. and Oliveira, A.G. (2001) Inclusion complex of piroxicam with R-cyclodextrin and incorporation in cationic microemulsion. In vitro drug release and in vivo topical anti-inflammatory effect. Int. J. Pharm., 222, 45-55.
68. Biruss, B., Kahlig, H. and Valenta, C. (2007) Evaluation of an eucalyptus oil containing topical drug delivery system for selected steroid hormones. Int. J. Pharm., 328, 142-151.
69. Lehmann, L., Keipert, S. and Gloor, M. (2001) Effects of microemulsions on the stratum corneum and hydrocortisone penetration. Eur. J. Pharm. Biopharm., 52, 129-136.
70. Cui, Z., Fountain, W., Clark, M., Jay, M. and Mumper, R. (2003) Novel ethanol-in-fluorocarbon microemulsions for topical genetic immunization. Pharm. Res., 20, 16-23.
71. Cui, Z. and Sloat, B.R. (2006) Topical immunization onto mouse skin using a microemulsion incorporated with an anthrax protective antigen protein-encoding plasmid. Int. J. Pharm., 317, 187-191.
72. Gershanik, T. and Benita, S. (2000) Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur. J. Pharm. Biopharm., 50, 179-188.
73. Pouton, C.W. (2000) Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur. J. Pharm. Sci., 11, S93-S98.
74. Koga, K., Kawashima, S. and Murakami, M. (2002) In vitro and in situ evidence for the contribution of labrasol and gelucire 44/14 on transport of cephalexin and cefoperazone by rat intestine. Eur. J. Pharm. Biopharm., 54, 311-318.
75. Rege, B.D., Kao, J. and Pollia, J. (2002) Effects of non-ionic surfactants on membrane trans-porters in Caco-2 cell monolayers. Eur. J. Pharm. Sci., 16, 237-246.
76. Hugger, E.D., Audus, K.L. and Borchardt, R.T. (2002) Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers. J. Pharm. Sci., 91, 1980-1990.
77. Sha, X., Yan, G., Wu, Y., Li, J. and Fang, X. (2005) Effect of self-microemulsifying drug delivery systems containing labrasol on tight junctions in Caco-2 cells. Eur. J. Pharm. Sci., 24, 477-486.
78. El-Sherbiny, D.T., El-Enany, N., Belal, F. and Hansen, S. (2007) Simultaneous determination of loratadine and desloratadine in pharmaceutical preparations using liquid chromatography with a microemulsion as eluent. J. Pharm. Biomed. Anal., 43, 1236-1242.
79. Ghosh, P.K., Majithiya, R.J., Umrethia, M.L. and Murthy, R.S.R. (2006) Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability. AAPS Pharmscitech, 7, 77.
80. Mountfield, R.J., Senepin, S., Schleimer, M., Walter, I. and Bittner, B. (2000) Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450. Int. J. Pharm., 211, 89-92.
81. Hauss, D.J., Fogal, S.E., Ficorilli, J.V., Price, C.A., Roy, T., Jayaraj, A.A. and Keirns, J.J. (1998) Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J. Pharm. Sci., 87, 164-169.
82. O'Driscoll, C.M. (2002) Lipid-based formulations for intestinal lymphatic delivery. Eur. J. Pharm. Sci., 15, 405-415.
83. Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K., Nishihara, Y. and Masuda, K. (2002) Microemulsion formulation for enhanced absorption of poorly soluble drugs II. In vivo study. J. Control. Release, 81, 75-82.
84. Cornaire, G., Woodley, J., Hermann, P., Cloarec, A., Arellano, C. and Houin, G. (2004) Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int. J. Pharm., 278, 119-131.
85. Hugger, E.D., Novak, B.L., Burton, P.S., Audus, K.L. and Borchardt, R.T. (2002) Comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. J. Pharm. Sci., 91, 1991-2002.
86. Bernkop-Schnurch, A. and Grabovac, V. (2006) Polymeric efflux pump inhibitors in oral drug delivery. Am. J. Drug Deliv., 4, 263-272.
87. Subramanian, N., Ray, S., Ghosal, S.K., Bhadra, R. and Moulik, S.P. (2004) Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biol. Pharm. Bull., 27, 1993-1999.
88. Holt, D.W., Mueller, E.A., Kovarik, J.M., van Bree, J.B. and Kutz, K. (1994) The pharmacoki-netics of sandimmune neoral: A new oral formulation of cyclosporine. Transplant. Proc., 26, 2935-2939.
89. Jing, O., Shen, Y., Ren, F., Chen, J., Jiang, Z., Peng, B., Leng, Y. and Dong, J. (2006) HPLC determination of anethole trithione and its application to pharmacokinetics in rabbits. J. Pharm. Biomed. Anal., 42, 613-617.
90. Porter, C., Kaukonen, A.M., Boyd, B.J., Edwards, G. and Charman, W.N. (2004) Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation. Pharm. Res., 21, 1405-1412.
91. Shen, H.R. and Zhong, M.K. (2006) Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. J. Pharm. Pharmacol., 58, 1183-1191.
92. Wu, W., Wang, Y. and Que, L. (2006) Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur. J. Pharm. Biopharm., 63, 288-294.
93. Cui, S., Zhao, C., Chen, D. and He, Z. (2005) Self-microemulsifying drug delivery systems (SMEDDS) for improving in vitrodissolution and oral absorption of pueraria lobata isoflavone. Drug Dev. Ind. Pharm., 31, 349-356.
94. Yang, S., Gursoy, N., Lambert, G. and Benita, S. (2004) Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors. Pharm. Res., 21, 261-270.
95. Heo, M.Y., Piao, Z.Z., Kim, T.W., Cao, O.R., Kim, A. and Lee, B.J. (2005) Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole. Arch. Pharm. Res., 28, 604-611.
96. Itoh, K., Tozuk, Y., Oguchi, T. and Yamamoto, K. (2002) Improvement of physicochemical properties of N-4472 Part II: Characterization of N-4472 microemulsion and the enhanced oral absorption. Int. J. Pharm., 246, 75-83.
97. Khoo, S.M., Humberstone, A.J., Porter, C.J.H. and Edwards, G.A. (1998) Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of Halofantrin. Int. J. Pharm., 167, 155-164.
98. Kim, C.K., Cho, Y.J. and Gao, Z.G. (2001) Preparation and evaluation of biphenyl dimethyl dicarboxylate microemulsions for oral delivery. J. Control Release, 70, 149-155.
99. Gao, Z.G., Choi, H.G., Shin, H.J., Park, K.M. and Lim, S.J. (1998) Physicochemical charac-terization and evaluation of a microemulsion system for oral delivery of cyclosporin A. Int. J. Pharm., 161, 75-86.
100. Constantinides, P.P. (1995) Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects. Pharm. Res., 11, 1561-1572.
101. Constantinides, P.P., Lancaster, C.M., Marcello J., Chiossone, D.C., Orner, D., Hidalgo, I., Smith, P., Sarkahian, A.B., Yiv, S.H. and Owen, A.J. (1995) Enhanced intestinal absorption of an RGD peptide from water-in oil microemulsions of different composition and particle size. J. Control Release, 34, 109-116.
102. Lyons, K.C., Charman, W.N., Miller, R. and Porter, C.J.H. (2000) Factors limiting the oral bioavailability of N-acetylglucosaminyl-N-acetylmuramyl dipeptide (GMDP) and enhancement of absorption in rats by delivery in a water-in-oil microemulsion. Int. J. Pharm., 199, 17-28.
103. Çelebi, N., Türkyilmaz, A., Gönül, B. and özogul, C. (2002) Effects of epidermal growth factor microemulsion formulation on the healing of stress-induced gastric ulcers in rats. J. Control Release, 83, 197-210.
104. Çilek, A., Çelebi, N., Tirnaksiz, F. and Tay, A. (2005) A lecithin-based microemulsion of rh-Insulin with aprotinin for oral administration: Investigation of hypoglycemic effects on non-diabetic and STZ-induced diabetic rats. Int. J. Pharm., 298, 176-185.
105. Kim, S.K., Lee, E.H., Bagalkot, V., Lee, S., Lee, Y.K., Kim, C.Y., Moon, H.T. and Byun, Y. (2005) Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates. J. Control Release, 105, 32-42.
106. Zheng, J.Y. and Fulu, M.Y. (2006) Decrease of genital organ weights and plasma testosterone levels in rats following oral administration of leuprolide microemulsion. Int. J. Pharm., 307, 209-215.
107. Yalkowsky, S.H., Krzyzaniak, J.F. and Ward, G.H. (1998) Formulation-related problems associ-ated with intravenous drug delivery. J. Pharm. Sci., 87, 787-796.
108. Lee, J.M., Park, K.M., Lee, S.J., Lee, M.K. and Kim, C.K. (2002) Microemulsion formulation of clonixic acid: Solubility enhancement and pain reduction. J. Pharm. Pharmacol., 54, 43-49.
109. Brime, B., Moreno, M., Frutos, G., Ballestros, M.P., Frutos, P. (2002) Amphotericin B in oil-water lecithin-based microemulsions: Formulation and toxicity evaluation. J. Pharm. Sci., 91, 1178-1185.
110. Junping, W., Takayama, K., Nagai, T. and Maitani, Y. (2003) Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol. Int. J. Pharm., 251, 13-21.
111. Söderlind, E., Wollbratt, M. and Corswant, C.V. (2003) The usefulness of sugar surfactants as solubilizing agents in parenteral formulations. Int. J. Pharm., 252, 61-71.
112. Jumaa, M. and Mueller, B.W. (2002) Parenteral emulsions stabilized with a mixture of phos-pholipids and PEG-660-12-hydroxy-stearate: Evaluation of accelerated and long-term stability. Eur. J. Pharm. Biopharm., 54, 207-212.
113. Corswant, C.V., Thorean, P. and Engstrom, S. (1998) Triglyceride-based microemulsion for intravenous administration of sparingly soluble substances. J. Pharm. Sci., 87, 200-208.
114. Park, K.M., Lee, M.K., Hwang, K.J. and Kim, C.K. (1999) Phospholipid-based microemulsions of flurbiprofen by the spontaneous emulsification process. Int. J. Pharm., 183, 145-154.
115. Brime, B., Molero, G., Frutos, P. and Frutos, G. (2004) Comparative therapeutic efficacy of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and deoxycholate-amphotericin B in immunocompetent and neutropenic mice infected with Candida albicans. Eur. J. Pharm. Sci., 22, 451-458.
116. Zhang, L., Sun, X. and Zhang, Z.R. (2005) An investigation on liver-targeting microemulsions of norcantharidin. Drug Deliv., 12, 289-295.
117. Jarvinen, K., Jarvinen, T. and Urtti, A. (1995) Ocular absorption following topical delivery. Adv. Drug. Deliv. Rev., 16, 3-19.
118. Ding, S. (1998) Recent developments in ophthalmic drug delivery. Pharm. Sci. Tech. Today, 1, 328-335.
119. Urtti, A. (2006) Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv. Drug. Deliv. Rev., 58, 1131-1135.
120. Kaur, I.P. and Knawar, M. (2002) Ocular preparations: The formulation approach. Drug Dev. Ind. Pharm., 28, 473-493.
121. Sultana, Y., Jain, R., Aqil, M. and Ali, A. (2006) Review of ocular drug delivery. Curr. Drug Deliv., 3, 207-217.
122. Liu, Z., Li, J., Nie, S. and Pan, W. (2006) Effects of transcutol P on the corneal permeability of drugs and evaluation of its ocular irritation of rabbit eyes. J. Pharm. Pharmacol., 58, 45-50.
123. Gasco, M.R., Gallarate, M., Trotta, M., Bauchiero, L., Gremmo, E. and Chiappero, O. (1989) Microemulsions as topical deliveryvehicles: Ocular administration of timolol. J. Pharm. Biomed. Anal., 7, 433-439.
124. Gallarate, M., Gasco, M.R., Trotta, M., Chetoni, P. and Saettone, M.F. (1993) Preparation and evaluation in vitro of solutions and O/W microemulsions containing levobunolol as ion-pair. Int. J. Pharm., 100, 219-225.
125. Siebenbrodt, I. and Keipert, S. (1993) Poloxamer-systems as potential ophthalmic microemul-sions. Eur. J. Pharm. Biopharm., 39, 25-30.
126. Halle, A. and Keipert, S. (1997) Development and characterization of microemulsions for ocular application. Eur. J. Pharm. Biopharm., 43, 179-183.
127. Fialho, S.L. and Silva-Cunha, A. (2004) New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin. Exp. Ophthalmol., 32, 626-632.
128. Alany, R.G., Rades, T., Nicoll, J., Tucker, I.G. and Davies, N.M. (2006) W/O microemulsions for ocular delivery: Evaluation of ocular irritation and precorneal retention. J. Control. Release, 111, 145-152.
129. Chan, J., Maghraby, G., Craig, J.P. and Alany, R.G. (2007) Phase transition water-in-oil mi-croemulsions as ocular drug delivery systems: In vitro and in vivo evaluation. Int. J. Pharm., 328, 65-71.
130. Li, L., Nandi, I. and Kim, K.H. (2002) Development of an ethyl laurate-based microemulsion for rapid-onset intranasal delivery of diazepam. Int. J. Pharm., 237, 77-85.
131. Zhang, O., Jiang, X., Jiang, W., Lu, W., Su, L. and Shi, Z. (2004) Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. Int. J. Pharm., 275, 85-96.
132. Vyas, T.K., Babbar, A.K., Sharma, R.K. and Misra, A. (2005) Intranasal mucoadhesive mi-croemulsions of Zolmitriptan: Preliminary studies on brain-targeting. J. Drug Target., 13, 317-324.
133. Vyas, T.K., Babbar, A.K., Sharma, R.K. and Misra, A. (2006) Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan. AAPS Pharmscitech, 7, Article 8.
134. Scherlund, M., Malmsten, M., Holmqvist, P. and Brodin, A. (2000) Thermosetting microemul-sions and mixed micellar solutions as drug delivery systems for periodontal anesthesia. Int. J. Pharm., 194, 103-116.
135. Ceschel, G.C., Maffei P., MorettiM.D.L., Demontis, S. and Peana, A.T. (2000) In vitropermeation through porcine buccal mucosa of salvia desoleana Atzei and Picci essential oil from topical formulations. Int. J. Pharm., 195, 171-177.
136. D'Cruz, J., Yiv, S.H. and Uckun, F.M. (2001) GM-144, A novel lipophilic vaginal contraceptive gel-microemulsion. AAPS Pharmscitech, 2, Article 5.
137. Sommerville, M.L., Johnson, C.S., Cain, J.B., Rypacek, F. and Hickey, A.J. (2002) Lecithin microemulsions in dimethyl ether and propane for the generation of pharmaceutical aerosols containing polar solutes. Pharm. Dev. Tech., 7, 273-288.
138. Sommerville, M.L. and Hickey, A.J. (2003) Aerosol generation by metered-dose inhalers con-taining dimethyl ether/propane inverse microemulsions. AAPS Pharmscitech, 4, Article 58.
139. Wissing, S., Kayser, O. and Müller, R.H. (2004) Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug. Deliv. Rev., 56, 1257-1272.
140. Mumper, R.J. and Oyewumi, M.O. (2002) Gadolinium loaded nanoparticles engineered from microemulsion templates. Drug Dev. Ind. Pharm., 28, 317-328.
141. Joshi, M.D. and Patravale, V.B. (2006) Formulation and evaluation of nanostructured lipid carrier (NLC) based gel of valdecoxib. Drug Dev. Ind. Pharm., 32, 911-918.
142. Eastoe, J., Hollamby, M.J. and Hudson, L. (2006) Recent advances in nanoparticle synthesis with reversed micelles. Adv. Col. Int. Sci., 128-130, 5-15.
143. Date, A.A. and Patravale, V.B. (2004) Current strategies for engineering drug nanoparticles. Curr. Opin. Coll. Int. Sci., 9, 222-235.
144. Trotta, M., Gallarate, M., Carlotti, M.E. and Morel, S. (2003) Preparation of griseofulvin nanoparticles from water-dilutable microemulsions. Int. J. Pharm., 254, 235-242.
145. Holmberg, K. (2004) Surfactant-templated nanomaterials synthesis. J. Coll. Int. Sci., 274, 355-364.
146. Andersson, M. and Jan-Erik Löfroth, J. (2003) Small particles of a heparin/chitosan complex prepared from a pharmaceutically acceptable microemulsion. Int. J. Pharm., 257, 305-309.
147. Nesamony, J. and Kolling, W. (2005) IPM/DOSS/Water microemulsions as reactors for silver sulfadiazine nanocrystal synthesis. J. Pharm. Sci., 94, 1310-1320.
148. Xu, X.J. and Gan, L.M. (2005) Recent advances in the synthesis of nanoparticles of polymer latexes with high polymer-to-surfactant ratios by microemulsion polymerization. Curr. Opin. Col. Int. Sci., 10, 239-244.
149. Watnasirichaikul, S., Tucker, I.G., Davies, N.M. and Rades, T. (2000) Preparation of biodegrad-able insulin nanocapsules from biocompatible microemulsions. Pharm. Res., 17, 684-689.
150. Watnasirichaikul, S., Tucker, I.G., Davies, N.M. and Davies N.M. (2002) In-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion. J. Pharm. Pharmacol., 54, 473-480.
151. Watnasirichaikul, S., Rades, T., Tucker, I.G. and Davies N.M. (2002) Effects of formulation variables on characteristics of poly (Ethylcyanoacrylate) nanocapsules prepared from W/O microemulsions. Int. J. Pharm., 235, 237-246.
152. Krauel, K., Graf, A., Hook, S., Davies, N.M. and Rades, T. (2006) Preparation of poly (Alkyl-cyanoacrylate) nanoparticles by polymerization of water-free microemulsions. J. Microencapsul., 23, 499-512.
153. De, T.K. and Hoffman, A.S. (2001) A reverse microemulsion polymerization method for prepa-ration ofbioadhesive polyacrylic acid nanoparticles for mucosal drug deliv.: Loading and release of Timolol Maleate. Art. Cells, Blood Subst. Immob. Biotech., 29, 31-46.
154. De, T.K, Rodman, D.J., Holm, B.A., Prasad, P.N. and Bergey, E.J. (2003) Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery. J. Microencapsul., 20, 361-374.
155. Marsh, A., Clark, B. and Altria, K. (2004) Oil-in-water microemulsion high performance liquid chromatographic analysis of pharmaceuticals. Chromatographia, 59, 531-542.
156. Altria, K., Marsh, A. and Clark, B. (2006) High performance liquid chromatographic analysis of pharmaceuticals using oil-in-water microemulsion eluent and monolithic column. Chro-matographia, 63, 309-314.
157. Marsh, A., Clark, B. and Altria, K. (2005) Oil-in-water microemulsion LC determination of pharmaceuticals using gradient elution. Chromatographia, 61, 539-547.
158. Altria, K., Broderick, M., Donegan, S. and Power, J. (2005) Preliminary study on the use of water-in-oil microemulsion eluents in HPLC. Chromatographia, 62, 341-348.
159. Jancic, B., Ivanovic, D., Medenica, M., Malenovic, A. and Dimkovic, N. (2005) Development of liquid chromatographic method for fosinoprilat determination in human plasma using microemulsion as eluent. J. Chromatogr. A, 1088, 187-192.
160. Malenovic, A., Medenica, M., Ivanovic, D. and Jancic, B. (2006) Monitoring of simvastatin impurities by HPLC with microemulsion eluents. Chromatographia, 63, S95-S100.
161. Jancic, B., Ivanovic, D., Medenica, M., Jancic, B. and Markovic, S. (2006) Influence of struc-tural and interfacial properties of microemulsion eluent on chromatographic separation of simvastatin and its impurities. J. Chromatogr. A, 1131, 67-73.
162. Mcevoy, E., Donegan, S., Power, J. and Altria, K. (2007) Optimisation and validation of a rapid and efficient microemulsion liquid chromatographic (MELC) method for the determination of paracetamol (Acetaminophen) content in a suppository formulation. J. Pharm. Biomed. Anal., 44, 137-143.
163. Cui, S., Fu, B., Lee, S.C. and Wang, X. (2005) Application of microemulsion thin layer chro-matography for the fingerprinting of licorice (Glycyrrhiza spp.). J. Chromatogr. B, 828, 33-40.